within Pharmacolibrary.Drugs.ATC.L;

model L01CB02
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.000225,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0074,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0065,
    k12             = 30,
    k21             = 30
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L01CB02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Teniposide is a semisynthetic derivative of podophyllotoxin with antineoplastic activity, acting as a topoisomerase II inhibitor to block DNA synthesis and induce apoptosis. It is primarily used for the treatment of childhood acute lymphoblastic leukemia and is approved for use in various countries, though its utilization may be limited due to toxicity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in pediatric patients with acute lymphoblastic leukemia, following intravenous infusion.</p><h4>References</h4><ol><li><p>Clark, PI, &amp; Slevin, ML (1987). The clinical pharmacology of etoposide and teniposide. <i>Clinical pharmacokinetics</i> 12(4) 223–252. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198712040-00001&quot;>10.2165/00003088-198712040-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3297462/&quot;>https://pubmed.ncbi.nlm.nih.gov/3297462</a></p></li><li><p>Montaldo, PG, et al., &amp; D&#x27;Incalci, M (1990). Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion. <i>Oncology</i> 47(1) 55–61. DOI:<a href=&quot;https://doi.org/10.1159/000226785&quot;>10.1159/000226785</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2300386/&quot;>https://pubmed.ncbi.nlm.nih.gov/2300386</a></p></li><li><p>He, S, et al., &amp; Zhang, Q (2012). A cremophor-free self-microemulsified delivery system for intravenous injection of teniposide: evaluation in vitro and in vivo. <i>AAPS PharmSciTech</i> 13(3) 846–852. DOI:<a href=&quot;https://doi.org/10.1208/s12249-012-9809-0&quot;>10.1208/s12249-012-9809-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22644709/&quot;>https://pubmed.ncbi.nlm.nih.gov/22644709</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L01CB02;
